Zoe oz & healthcorps, inc.
SURVIVOR SPOTLIGHT MATT KLEIN Young Adult Survivor Hodgkin's Disease ZOE OZ Daughter, Dr. Mehmet Oz Youth Health Advocate Blogger, teenDailyStrength.com Contributor, YOU: The Owner's Manual for Teens AMY BARONE Director of Communications HealthCorps SARAH FRANK Coordinator, HeathCorps West Side High School NYC (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - September 20, 2011 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Zoe oz & healthcorps, inc. - 九月 20,2011
SURVIVOR SPOTLIGHT MATT KLEIN Young Adult Survivor Hodgkin's Disease ZOE OZ Daughter, Dr. Mehmet Oz Youth Health Advocate Blogger, teenDailyStrength.com Contributor, YOU: The Owner's Manual for Teens AMY BARONE Director of Communications HealthCorps SARAH FRANK Coordinator, HeathCorps West Side High School NYC (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - September 20, 2011 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Zoe oz & healthcorps, inc.
SURVIVOR SPOTLIGHT
MATT KLEIN
Young Adult Survivor
Hodgkin's Disease ZOE OZ
Daughter, Dr. Mehmet Oz
Youth Health Advocate
Blogger, teenDailyStrength.com
Contributor, YOU: The Owner's Manual for Teens AMY BARONE
Director of Communications
HealthCorps SARAH FRANK
Coordinator, HeathCorps
West Side High School NYC (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - September 20, 2011 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Risk of Lymphoma Associated With Combination Anti –Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease
Dr. Bruce Sands looks at the rate of non-Hodgkin's lymphoma in adult Crohn's disease patients who have received anti-TNF therapy, compared with that of a population-based registry and a populationof CD patients treated with immunomodulators. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 29, 2009 Category: Gastroenterology Authors: AGA Source Type: podcasts
Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease
Dr. Bruce Sands looks at the rate of non-Hodgkin's lymphoma in adult Crohn's disease patients who have received anti-TNF therapy, compared with that of a population-based registry and a populationof CD patients treated with immunomodulators. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 29, 2009 Category: Gastroenterology Authors: AGA Source Type: podcasts
